Melinta Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2000-01-01
- Employees
- 290
- Market Cap
- -
- Website
- http://melinta.com
Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections
Phase 2
Completed
- Conditions
- Skin Structure InfectionsBacterial Skin DiseasesStaphylococcal Skin Infections
- Interventions
- First Posted Date
- 2008-07-22
- Last Posted Date
- 2014-07-14
- Lead Sponsor
- Melinta Therapeutics, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT00719810
- Locations
- 🇺🇸
Physician Alliance Research Center, Anaheim, California, United States
🇺🇸Quality of Life Medical Center, LLC, Hawaiian Gardens, California, United States
🇺🇸Tri City Medical Center, Oceanside, California, United States
Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections
Phase 2
Completed
- Conditions
- Infectious Skin DiseasesBacterial Skin DiseasesStaphylococcal Skin InfectionsStreptococcal InfectionsAbscess
- Interventions
- First Posted Date
- 2008-03-31
- Last Posted Date
- 2014-03-27
- Lead Sponsor
- Melinta Therapeutics, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT00646958
- Locations
- 🇺🇸
Drug Research & Analysis Corp, Montgomery, Alabama, United States
🇺🇸OWENS Pharma Research Center, Long Beach, California, United States
🇺🇸Healthcare Partners Medical Group, Los Angeles, California, United States
Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia
- First Posted Date
- 2008-03-21
- Last Posted Date
- 2016-05-12
- Lead Sponsor
- Melinta Therapeutics, Inc.
- Target Recruit Count
- 158
- Registration Number
- NCT00640926
- Locations
- 🇺🇸
eStudySite, San Diego, California, United States
🇺🇸Olive View- UCLA Center, Dept. Emergency Medicine, Sylmar, California, United States
🇺🇸Wayne State University School of Medicine/Detroit Receiving Hospital, Detroit, Michigan, United States